ARS Pharmaceuticals Inc (SPRY)
13.38
-0.17
(-1.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.21
-0.17
(-1.27%)
Pre-Market: 09:12
ARS Pharmaceuticals Total Liabilities (Quarterly): 16.62M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.62M |
| June 30, 2024 | 6.725M |
| March 31, 2024 | 3.715M |
| December 31, 2023 | 2.428M |
| September 30, 2023 | 11.27M |
| Date | Value |
|---|---|
| June 30, 2023 | 10.20M |
| March 31, 2023 | 10.04M |
| December 31, 2022 | 8.549M |
| June 30, 2022 | 90.08M |
| December 31, 2021 | 92.72M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.428M
Minimum
Dec 2023
92.72M
Maximum
Dec 2021
25.23M
Average
10.12M
Median
Total Liabilities (Quarterly) Benchmarks
| Exelixis Inc | 684.86M |
| Assembly Biosciences Inc | 74.26M |
| Protagonist Therapeutics Inc | 71.94M |
| Precision BioSciences Inc | 88.39M |
| Avidity Biosciences Inc | 137.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.60M |
| Shareholders Equity (Quarterly) | 200.98M |
| Current Ratio | 12.56 |